KAT2B c.1750-962C>T

Variant ID: 3-20177472-C-T

NM_003884.4(KAT2B):c.1750-962C>T

This variant was identified in 4 publications

View GRCh38 version.




Publications:


Human Genetics of Addiction: New Insights and Future Directions.

Current Psychiatry Reports
Hancock, Dana B DB; Markunas, Christina A CA; Bierut, Laura J LJ; Johnson, Eric O EO
Publication Date: 2018-03-05

Variant appearance in text: rs9829896
PubMed Link: 29504045
Variant Present in the following documents:
  • Main text
View BVdb publication page



A Review of Genome-Wide Association Studies of Stimulant and Opioid Use Disorders.

Molecular Neuropsychiatry
Jensen, Kevin P KP
Publication Date: 2016-05

Variant appearance in text: rs9829896
PubMed Link: 27606319
Variant Present in the following documents:
  • Main text
View BVdb publication page



Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma.

World Journal Of Gastroenterology
Nan, Yue-Li YL; Hu, Yan-Ling YL; Liu, Zhi-Ke ZK; Duan, Fang-Fang FF; Xu, Yang Y; Li, Shu S; Li, Ting T; Chen, Da-Fang DF; Zeng, Xiao-Yun XY
Publication Date: 2016-06-28

Variant appearance in text: rs9829896
PubMed Link: 27350734
Variant Present in the following documents:
  • Main text
View BVdb publication page



KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.

Addiction Biology
Johnson, Eric O EO; Hancock, Dana B DB; Levy, Joshua L JL; Gaddis, Nathan C NC; Page, Grier P GP; Glasheen, Cristie C; Saccone, Nancy L NL; Bierut, Laura J LJ; Kral, Alex H AH
Publication Date: 2016-11

Variant appearance in text: rs9829896
PubMed Link: 26202629
Variant Present in the following documents:
  • Main text
View BVdb publication page